Short Course Oncology Therapy(SCOT). A study of post operative chemotherapy for 12 weeks versus 24 weeks with oxaliplatin/Fluorouracil (5FU) to establish disease free survival outcomes in locally advanced colon cancer
Latest Information Update: 17 Jun 2024
At a glance
- Drugs Capecitabine (Primary) ; Oxaliplatin (Primary) ; Fluorouracil
- Indications Colorectal cancer
- Focus Therapeutic Use
- Acronyms SCOT
- 08 Jun 2021 Results from 6 randomised trials NCT00749450, NCT00646607, NCT01150045, NCT00958737) in the IDEA database used to compare characteristics, tx adherence, and adverse events presented at the 57th Annual Meeting of the American Society of Clinical Oncology.
- 13 Jan 2021 Results of the pooled analysis of the high-risk stage II disease individual patient data from the four studies within the IDEA collaboration published in the Journal of Clinical Oncology
- 14 Dec 2013 Accrual to date is 102% according to United Kingdom Clinical Research Network record.